On their first date, Jane* and her partner fell in love over cooking. They bonded over spices, argued over flavours, and ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

Curious about Ozempic benefits? Here’s who could benefit from using these medications—and why they’re not just for weight ...

The high monthly costs of GLP-1s — ranging from $1,000 to $1,500 — are placing considerable financial pressure on healthcare ...

Denmark's Novo Nordisk faces mounting pressure — from cheap copycats to US tariff threats — putting its weight-loss empire at ...

The Liberal Party was not only the most successful political movement of the 19th century, but defined an entire period of ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

That is the kind of half-joking question that doctors kick around when a new class of drugs begins to help a big chunk of the ...

Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...